LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic ...Middle East

PR Newswire - News
SEOUL, South Korea, Aug. 1, 2021 /PRNewswire/ -- LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis...

Hence then, the article about liscure biosciences announces know how license agreement and stock purchase agreement with mayo clinic was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News